Rep. Josh Gottheimer (D-NJ) has filed a Periodic Transaction Report under the STOCK Act disclosing a purchase of American Depositary Shares of NICE Ltd (NICE), each representing one ordinary share of the Israeli enterprise software company. The transaction was executed on July 20, 2026, through a jointly-held account shared with his spouse, and the disclosed value falls between $1,001 and $15,000, the lowest reporting bracket used in these filings.
The trade was made through a Morgan Stanley Select UMA account, one of several brokerage accounts Gottheimer has used in past disclosures to manage jointly-held investments. Because the transaction was purchased rather than sold, whoisbuyingnow.com classifies this filing as a congress buy signal, indicating new or increased exposure to the company rather than a reduction in an existing position.
A Notable Timing Overlap
What makes this filing worth flagging is its proximity to activity on the corporate insider side. Company insider Dayan Udi Yehuda sold NICE shares on August 7, 2026, at a price of $153, a transaction that falls within 30 days of Gottheimer’s disclosed purchase. Insider sales and congressional stock purchases occurring close together are not evidence of coordination or wrongdoing, and STOCK Act filings exist precisely so that lawmakers’ financial activity can be tracked transparently. Still, when a member of Congress buys into a stock around the same window that a company insider is selling out of it, the timing overlap becomes a natural point of interest for anyone following disclosure patterns.
NICE Ltd, listed on the Nasdaq under the ticker NICE, provides cloud-based enterprise software, including customer engagement and financial crime prevention platforms used by large institutions. Its ADS structure means each share traded on U.S. exchanges represents one ordinary share of the underlying Israeli company, a common arrangement for foreign firms seeking U.S. investor access.
Gottheimer represents New Jersey’s 5th congressional district and sits on the House Financial Services Committee, a panel whose members frequently disclose trades in financial and technology-adjacent companies. As with all Periodic Transaction Reports, this filing reflects a legally required disclosure rather than a recommendation or judgment about the merits of the trade. The report does not specify the exact number of shares purchased, only the dollar range, which is standard practice under STOCK Act reporting rules.
Readers tracking congressional trading patterns alongside insider activity can watch for any follow-up filings from Gottheimer’s office, as well as additional Form 4 disclosures tied to NICE Ltd insiders, to see whether this timing overlap develops into a broader pattern or remains an isolated coincidence.